Last reviewed · How we verify
Ethyl Alcohol 7%
At a glance
| Generic name | Ethyl Alcohol 7% |
|---|---|
| Sponsor | Hospital Regional de Alta Especialidad del Bajio |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Antiplaque Efficacy and Patient Reported Outcome of Chlorohexidine, Cetylpyridinium Chloride, and Essential Oil Mouthwashes in Orthodontic Patients (NA)
- Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor (NA)
- Recovery Initiation and Management After Overdose (RIMO) Experiment (NA)
- Gastric Emptying With Trou Normand (NA)
- Validity of the Turkish Situational Vertigo Questionnaire
- Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip Surgeries (PHASE3)
- Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
- Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ethyl Alcohol 7% CI brief — competitive landscape report
- Ethyl Alcohol 7% updates RSS · CI watch RSS
- Hospital Regional de Alta Especialidad del Bajio portfolio CI